Several tumour-derived molecules act as major drivers of DC malfunction13,43 and engage the p38-MK2 pathway for signal transduction44,45, exemplifying how MK2 could be exploited to relay environmental cues to modulate DC behaviour. The gene discussed is MAPKAPK2; the disease is neoplasm.